The Global Health Policy Center leads CSIS’s research bridging foreign policy and public health communities.

Sign and logo of the Center William Rappard, home of the World Trade Organization (WTO)

TRIPS Waivers and Pharmaceutical Innovation

TRIPS waivers undermine the U.S. pharmaceutical industry by degrading the IP protections which are essential to the pharmaceutical innovation ecosystem. Less innovation in the pharmaceutical industry means fewer vaccines and drugs in the future, leaving the United States and other nations less prepared for future pandemics and other health emergencies.

Blog Post by Christopher Borges — March 15, 2023

See all analysis on Global Health

Latest Podcasts

See all podcasts on Global Health

Past Events

See all events on Global Health

Related Programs

Experts

Katherine E. Bliss

Katherine E. Bliss

Senior Fellow and Director, Immunizations and Health Systems Resilience, Global Health Policy Center

All content on Global Health

Filter by

11 - 20 of 999 results
Coronavirus Crisis Update

Dr. Scott Kennedy, CSIS: “Give us our lives back!”

In our continued series on China post-Zero Covid, Dr. Scott Kennedy recounts the revelations from his six weeks in Beijing and Shanghai in late 2022, and reflects on what has transpired–societally, politically, medically—since President Xi suddenly threw off the Zero Covid controls in early December. What is the toll for not preparing for the colossal peak of Covid? What will be made of a “crisis of confidence” that the government must face, and that is going to hurt? What can we expect in the spring in terms of normalization?

Podcast Episode by J. Stephen Morrison and Scott Kennedy — January 26, 2023

CSIS Coronavirus Crisis Update

Battling Biological Threats: Complacency, Progress, or Both?

The elevation of health security within recent national security policies and bipartisan legislative action proves that it remains possible to bridge divides and make measurable progress to prepare the United States for inevitable future biological threats. 

Commentary by Thomas Cullison and J. Stephen Morrison — January 20, 2023

Haiti Policy: Stumbling toward 2023

CSIS senior associate Georges A. Fauriol analyzes the current political and security challenges in Haiti and key trends to watch for in 2023.

Commentary by Georges A. Fauriol — January 13, 2023

Building the CDC the Country Needs

The CSIS Commission on Strengthening America’s Health Security’s bipartisan working group on the CDC recommends a package of reforms to strengthen CDC’s performance in preventing and responding to dangerous outbreaks and drive a significant reset within the agency.

Report by J. Stephen Morrison and Tom Inglesby — January 12, 2023

The Antimicrobial Resistance Challenge

Despite the pressing societal need to address the threat of AMR, the development and manufacturing of new antibiotics to fight these super-bugs face unique challenges within the U.S. biopharmaceutical innovation ecosystem.

Blog Post by Gregory Arcuri — January 3, 2023